Searchable abstracts of presentations at key conferences in endocrinology

ea0011p768 | Steroids | ECE2006

Phenotypic variability in P450 oxidoreductase deficiency may be caused by differential effects of P450 oxidoreductase mutations on steroidogenesis

Dhir V , Ivison HE , Doherty AJ , Stewart PM , Arlt W

Without adequate treatment patients with acromegaly die prematurely from cardiovascular disease (CVD); however the contribution of atherosclerosis in this process is controversial. Increased carotid IMT is an early morphological marker of atherosclerosis and predictor of subsequent cardiovascular events. Contradictory data exist regarding IMT in patients with acromegaly.We measured carotid IMT in 79 patients with acromegaly (47 male, mean age 55±14 ...

ea0029p9 | Adrenal cortex | ICEECE2012

Progressive adrenal insufficiency in a patient with 46,XY DSD caused by two novel mutations in the cytochrome P450 side-chain cleavage (CYP11A1) gene

Parajes S. , But B. , Chan A. , Rose I. , Taylor A. , Griffin A. , Dhir V. , Arlt W. , Krone N.

Background: Cytochrome P450 side-chain cleavage enzyme (CYP11A1) catalyses the first and rate-limiting step of steroidogenesis. CYP11A1 firstly converts cholesterol into 22R-hydroxycholesterol, which relies on mitochondrial steroidogenic acute regulatory protein (StAR)-mediated cholesterol import. Two further StAR-independent CYP11A1 reactions facilitate pregnenolone biosynthesis. CYP11A1 deficiency is rare and manifests with adrenal insufficiency (AI), and, in 46,XY individua...

ea0009oc14 | Oral Communication 2: Reproduction and growth | BES2005

Pathophysiology and genetics of congenital adrenal hyperplasia caused by P450 oxidoreductase deficiency

Dhir V , Ivison H , Walker E , Draper N , Hammer F , Malunowicz E , Stewart P , Shackleton C , Arlt W

We have recently identified inactivating mutations in the electron donor enzyme P450 oxidoreductase as the cause of disease in patients with apparent combined P450c17 and P450c21 deficiency, a variant of congenital adrenal hyperplasia (CAH) (1). Additionally, we suggested that P450 oxidoreductase deficiency (ORD) reveals the existence of an alternative pathway in human androgen synthesis present in fetal life only, explaining the concurrent presence of low circulating androgen...

ea0019oc10 | Neuroendocrine and Steroids | SFEBES2009

PAPSS2 deficiency: a novel monogenic cause of androgen excess

Dhir V , Noordam C , McNelis J , Schlereth F , Hanley N , Krone N , Smeitink J , Smeets R , Sweep F , Claahsen-van der Grinten H , Arlt W

Androgen excess is a key feature of the polycystic ovary syndrome; however the molecular mechanisms underlying its pathogenesis largely remain elusive. Dehydroepiandrosterone sulfate (DHEAS) is the most abundant steroid in the human circulation but only unconjugated dehydroepiandrosterone (DHEA) can be converted to active androgens. Conversely, conversion of DHEA to its sulfate ester DHEAS by DHEA sulfotransferase, SULT2A1, diminishes the DHEA pool available for androgen gener...

ea0017oc1 | Endocrinology 1 | BSPED2008

Functional and structural analysis of three novel mutations (A174E, V178D, L465P) in the CYP17A1 gene causing steroid 17-hydroxylase deficiency

Reisch N , Dhir V , Bleicken C , Lebl J , Kamrath C , Schwarz HP , Grotzinger J , Sippell WG , Riepe FG , Arlt W , Krone N

Steroid 17α-hydroxylase (CYP17A1) deficiency (17OHD) is a rare form of congenital adrenal hyperplasia (CAH). Both, 17-hydroxylase and 17,20-lyase reactions are catalysed by CYP17A1. Here, we analysed the structural and functional consequences of 3 novel CYP17A1 mutations found in 3 patients suffering from 17OHD. Two individuals with 46,XY DSD, presented with tall stature and one with arterial hypertension. Mutation screening of the CYP17A1 gene revealed comp...